PRELUDE CAPITAL MANAGEMENT, LLC - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 167 filers reported holding DIPLOMAT PHARMACY INC in Q3 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$75,000
+476.9%
18,810
+810.5%
0.00%
+200.0%
Q2 2019$13,000
+225.0%
2,066
+588.7%
0.00%
Q4 2018$4,000
+100.0%
300
+212.5%
0.00%
Q3 2018$2,000
-60.0%
96
-46.1%
0.00%
Q2 2018$5,000
-86.1%
178
-92.6%
0.00%
-100.0%
Q2 2017$36,000
-93.3%
2,405
-87.5%
0.00%
-94.6%
Q3 2016$538,000
+484.8%
19,200
+630.9%
0.06%
+330.8%
Q2 2016$92,000
-49.7%
2,627
-60.6%
0.01%
-50.0%
Q1 2016$183,000
-8.0%
6,664
+14.8%
0.03%
-16.1%
Q4 2015$199,0005,8070.03%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q3 2017
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 7,036,670$42,853,0001.54%
ARMISTICE CAPITAL, LLC 3,200,000$19,488,0001.23%
STEPHENS INC /AR/ 6,600,015$40,194,0000.91%
S&T BANK/PA 610,367$3,718,0000.82%
Rhenman & Partners Asset Management AB 1,203,405$7,329,0000.81%
Matarin Capital Management, LLC 701,445$4,272,0000.30%
Investors Research Corp 89,727$546,0000.28%
Advisory Services Network, LLC 598,802$3,647,0000.22%
FCG ADVISORS, LLC 34,000$207,0000.06%
EVERENCE CAPITAL MANAGEMENT INC 52,730$321,0000.05%
View complete list of DIPLOMAT PHARMACY INC shareholders